Inovio Pharmaceuticals Stock Earnings The value each INO share was expected to gain vs. the value that each INO share actually gained. Inovio Pharmaceuticals. The biopharmaceutical company reported ($) earnings per share (EPS) for the quarter, missing the consensus estimate of ($) by ($). Inovio. Get the latest Inovio Pharmaceuticals Inc (INO) real-time quote, historical performance, charts, and other financial information to help you make more. View Inovio Pharmaceuticals, Inc. INO stock quote prices, financial information, real-time forecasts, and company news from CNN. Stay up-to-date on Inovio Pharmaceuticals, Inc. Common Stock (INO) news with the latest updates, breaking headlines, news articles, and more from around the.
INO Inovio Pharmaceuticals ; High. ; Low. ; Volume. K ; Open. ; Pre Close. Monkeypox Fears Push Up Antiviral, Vaccine Stocks. The Scale of the Threat Is Unknown. Inovio's Covid Vaccine Shows Promise. Here's Why Its Stock Is Down. Latest Inovio News. August 8, INOVIO Reports Second Quarter Financial Results and Recent Business Highlights · (read more). July 25, Inovio. Research Inovio Pharmaceuticals' (Nasdaq:INO) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. INOVIO is leveraging a cutting-edge platform to advance DNA medicine candidates with the potential to transform disease prevention and treatment paradigms. Stock analysis for Inovio Pharmaceuticals Inc (INO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. Inovio Pharmaceuticals Inc INO:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date04/01/24 · 52 Week Low Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people. On Friday 08/02/ the closing price of the Inovio Pharmaceuticals Inc Registered Shs share was $ on BTT. Compared to the opening price on Friday 08/02/. Why Shares of Inovio Pharmaceuticals Were Down Tuesday The biotech stock, still reeling from a failed clinical trial, hit a week low. 2 Stocks. See charts, data and financials for Inovio Pharmaceuticals Inc INO.
Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based. Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO News Releases · August 8, INOVIO Reports Second Quarter Financial Results and Recent Business Highlights · August 1, INOVIO Reports Inducement. Inovio Pharmaceuticals (INO) · Premarket PM ET 08/23/ $ %. Previous Close · $ · ; % · Volume: , · Volume % Chg: 39%. Get Inovio Pharmaceuticals Inc (INO.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Inovio Pharmaceuticals Inc. · REAL TIME AM EDT 08/23/24 · USD · % · Volume, Recent News · Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors · Inovio Pharmaceuticals Inc. stock underperforms Monday when. Discover real-time Inovio Pharmaceuticals, Inc. Common Stock (INO) stock prices, quotes, historical data, news, and Insights for informed trading and. Track Inovio Pharmaceuticals Inc (INO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and.
What is the current stock price of Inovio Pharmaceuticals (INO)?. The current stock price of Inovio Pharmaceuticals (INO) is $ as of August 24, Inovio (INO) Soars %: Is Further Upside Left in the Stock? Inovio (INO) saw its shares surge in the last session with trading volume being higher than. Inovio Pharmaceuticals Inc News & Analysis · Gaucho Group: Strategic Appointment Underscores Commitment to Leveraging New Opportunities in Argentina's Evolving. Inovio shares eased after the drugmaker reported a wider loss. Earlier it had reported progress with its COVID vaccine candidate. INO. INO stock results show that Inovio Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of INO.
View the real-time INO price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. INO average Analyst price target in the past 3 months is $ Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts. Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases. The average one-year price target for Inovio Pharmaceuticals, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price.
Mns Chat | Best Dedicated Web Hosting